STOCK TITAN

SIGA Technologies Inc - SIGA STOCK NEWS

Welcome to our dedicated news page for SIGA Technologies (Ticker: SIGA), a resource for investors and traders seeking the latest updates and insights on SIGA Technologies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SIGA Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SIGA Technologies's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.64%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.31%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.89%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.05%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.03%
Tags
earnings
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.54%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.7%
Tags
clinical trial
SIGA Technologies Inc

Nasdaq:SIGA

SIGA Rankings

SIGA Stock Data

608.54M
40.28M
9.52%
49.58%
7.76%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
New York

About SIGA

at siga, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, ebola, dengue, lassa fever and other dangerous viruses. our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.